Concord Drugs Limited (BOM:538965)
India · Delayed Price · Currency is INR 83.95
+0.34 (0.41%)
At close: Feb 12, 2026
Concord Drugs Market Cap
Concord Drugs has a market cap or net worth of 1.12 billion as of February 13, 2026. Its market cap has increased by 196.25% in one year.
Market Cap
1.12B
Enterprise Value
1.31B
Revenue
450.74M
Ranking
n/a
PE Ratio
147.15
Stock Price
83.95
Market Cap Chart
Since February 23, 2015, Concord Drugs's market cap has increased from 144.80M to 1.12B, an increase of 674.38%. That is a compound annual growth rate of 20.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 12, 2026 | 1.11B | 1.78% |
| Dec 31, 2025 | 1.09B | 188.24% |
| Dec 31, 2024 | 377.00M | -36.87% |
| Dec 29, 2023 | 597.20M | 109.83% |
| Dec 30, 2022 | 284.61M | 1.24% |
| Dec 31, 2021 | 281.11M | 40.39% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bilcare | 1.57B |
| Parnax Lab | 1.44B |
| Pharmaids Pharmaceuticals | 1.41B |
| Sotac Pharmaceuticals | 1.38B |
| Lactose (India) | 1.33B |
| Bal Pharma | 1.18B |
| Mercury Laboratories | 966.18M |
| Makers Laboratories | 856.14M |